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Abstract
Background: Early detection of cholera outbreaks is crucial for the implementation of the most
appropriate control strategies.
Methods: The performance of an immunochromatographic dipstick test (Institute Pasteur, Paris,
France) specific for Vibrio cholerae O1 was evaluated in a prospective study in Beira, Mozambique,
during the 2004 cholera season (January-May). Fecal specimens were collected from 391 patients
with acute watery nonbloody diarrhea and tested by dipstick and conventional culture.
Results: The overall sensitivity and specificity of the rapid test compared to culture were 95%
(95% confidence interval [CI]: 91%–99%) and 89% (95% CI: 86%–93%), respectively. After
stratification by type of sample (rectal swab/bulk stool) and severity of diarrhea, the sensitivity
ranged between 85% and 98% and specificity between 77% and 97%.
Conclusion: This one-step dipstick test performed well in the diagnosis of V. cholerae O1 in a
setting with seasonal outbreaks where rapid tests are most urgently needed.
Background
The cardinal clinical feature of cholera is a severe dehy-
drating diarrhea, which can lead to severe and rapidly pro-
gressing dehydration and shock. Despite advances in the
understanding of its pathophysiology and transmission,
cholera remains a major international health concern. In
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2003, the World Health Organization (WHO) received
reports from 45 countries of 11,575 cholera cases and
1,894 related deaths. The majority of cholera cases
occurred in sub-Saharan Africa [1]. However, these num-
bers are considered gross underestimates since outbreaks
are often not reported due to fear of travel and trade sanc-
tions. Critical interventions for cholera control include
improved access to efficient treatment facilities, education
to promote good personal hygiene, and improvement of
sanitation and safe water supply [2-4]. But successful
interventions depend on early detection of cholera out-
breaks. Therefore, an efficient cholera surveillance system
should be a high priority in the control of cholera [1,5].
The conventional culture methods currently used for diag-
nosis of Vibrio cholerae remain the gold standard but
require a functioning laboratory and are time-consuming.
Microbiologic facilities are usually not available in chol-
era-endemic settings, which are frequently characterized
by abject poverty, or under emergency conditions such as
natural disasters, wars, refugee crises, and population dis-
placements. Thus, an accurate rapid bedside test would be
of enormous help for the early confirmation of a cholera
outbreak to enable preventive and control measures.
The Institute Pasteur, Paris, France has developed a one-
step immunochromatographic dipstick test for the rapid
diagnosis of V. cholerae from stool samples or enriched
rectal swabs. This diagnostic test has been evaluated in
Bangladesh and Madagascar, where it showed promising
levels of sensitivity and specificity [6,7]. However, both
evaluations were conducted in sites with a good research
infrastructure. These findings cannot necessarily be
extrapolated to sites in sub-Saharan Africa where most
reported cholera cases occur. We therefore evaluated the
Pasteur rapid cholera test in an endemic setting typical of
many urban areas of Sub-Saharan Africa and used conven-
tional bacteriological culture as the reference standard.
Methods
Study site and subjects
The port city of Beira in the province of Sofala is the sec-
ond largest city in Mozambique. It has a population of
approximately 450,000, divided among 22 districts (bair-
ros). Diarrhea is highly seasonal in Beira and coincides
with the rains that start in January, peak around April or
March, and end about June. In Beira, the Centros de Trata-
mento de Cólera (Cholera Treatment Centre [CTC]) man-
ages virtually all patients with watery diarrhea who
require treatment. After evaluation of clinical signs such as
dehydration, patients with severe dehydration are admit-
ted and treated with intravenous (IV) fluids; patients with
no or lesser dehydration are treated with oral rehydration
solution (ORS) and observed at the CTC for 4 hours or
longer. Diarrhea was defined as three or more loose bowel
movements during a 24-hour period. Cholera was defined
as a diarrhea episode during which V. cholerae were iso-
lated.
For this study stool samples (bulk stool/rectal swab) were
collected from consenting diarrhea cases who presented at
the CTC between 1 January 2004 and 31 May 200. Stool
samples were obtained by rectal catheter from patients
with acute watery nonbloody diarrhea. If patients refused
to have a rectal catheter inserted or the catheter failed to
produce stool, a rectal swab was obtained. Rectal swabs
were placed in Cary-Blair transport medium; bulk stool
was transported in disposable plastic containers. All spec-
imens were transported to a clinical laboratory within 2
hours of acquisition.
Bacteriological culture
Conventional bacteriological culture was applied as gold
standard against which we evaluated the accuracy of the IP
rapid test. Bulk stool or rectal swabs were plated directly
onto thiosulfate citrate bile salt sucrose (TCBS) agar and
taurocholate tellurite gelatin agar (TTGA) [8]. In addition,
the rectal swab was also plated onto TCBS and TTGA after
enrichment in alkaline peptone water (APW) for 6 hours
(pH 8.6, 37°C). After overnight incubation, suspected
colonies on the agar plates were selected for biochemical
test and agglutination with polyvalent, Ogawa, and Inaba
antisera (Difco Formulation, Detroit, Michigan). Nonag-
glutinating strains were tested with antiserum to V. chol-
erae O139 strain (Difco Formulation, Detroit, Michigan).
Dipstick test
The dipstick test utilizes monoclonal antibodies specific
to V. cholerae O1 lipopolysaccharide (LPS) and colloidal
gold particles based on a one-step, vertical flow immuno-
chromatography principle. The detection threshold with
purified LPS is 10 ng/ml for V. cholerae O1 [6].
In total, 200 µl of bulk stool was pipetted into a fresh tube
into which the test strip was inserted. The rectal swabs
were incubated for 6 hours in APW at 37°C after which
200 µl of the enrichment medium was also used for test-
ing. The test strips were read after 10 minutes of immer-
sion in the stool or in the APW suspension. The tests were
defined as positive when both a test line and control line
appeared on the test strip [6,7].
Technicians were trained for 2 weeks before the study start
to perform conventional culture and the IP rapid test by a
consultant from the Centre for Health and Population
Research, Dhaka, Bangladesh (ICDDR,B) with prior expe-
rience in the use of the assay. The same technicians con-
ducted the tests throughout the study period. The identity
of 58 (42%) of 137 V. cholerae isolates were confirmed at
the ICDDR,B.BMC Infectious Diseases 2006, 6:17 http://www.biomedcentral.com/1471-2334/6/17
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Data management and analysis
All information was double entered into a custom-made
data entry program (FoxPro, Microsoft, Redmond, Wash-
ington, USA). The data management program includes
both error and consistency checks.
The performance characteristics of the rapid test in differ-
ent conditions, sensitivity, specificity, positive predictive
value (PPV), Kappa coefficient, as well as 95% confidence
interval (CI) for sensitivity and specificity were calculated
[9]. Because of the close correlation between disease sever-
ity, intravenous rehydration and the type of specimen col-
lected, the performance characteristics were assessed in
four subgroups based on the specimen collected (bulk
stool or enriched rectal swab) and treatment received
(intravenous fluids or no intravenous fluids).
In the primary analysis, an intense test line (even in the
absence of a control line) was considered as positive
because it had been previously found that a heavy load of
V. cholerae O1 LPS in the sample would cause most of the
gold beads to bind with the LPS, resulting in an absent
control line. In a secondary analysis we considered tests
with an absent control line as invalid and excluded them
from the analysis. We used the Chi-square test for analysis
of binary data and a t-test for the continuous variables. To
explore the potential correlation between the perform-
ance characteristics of the test and the type of stool speci-
Table 1: Demographic and clinical features of diarrhea patients
Feature Cholera cases (N = 138) Non-Cholera diarrhea cases (N = 253) p value
Mean (SD) age 20.2 (15.9) 24.4 (15.6) <0.0001
Number (%) female 65 (47) 130 (51) = 0.42
Number (%) rehydrated intravenously 104 (75) 84 (33) <0.0001
Number (%) with severe dehydration a 24 (18) 14 (6) = 0.0002
Number (%) with vomiting b 122 (88) 187 (75) = 0.0012
Number (%) provided a rectal swab 66 (48) 153(61) = 0.016
a Data not available for 13 noncholeraic patients and 3 cholera patients.
b Data not available for 2 non-cholera patients.
Table 2: Stratified analysis of the sensitivity and specificity of cholera dipstick test according to specimen (bulk stool or enriched rectal 
swab) and treatment (intravenous fluids or no intravenous fluids)
Dipstick test Bacteriological culture Total
Positive Negative
IV treatment – enriched rectal swab a
Positive 45 3 38
Negative 0 40 40
Total 45 43 78
IV treatment – bulk stool b
Positive 57 10 67
Negative 2 31 33
Total 59 41 100
No IV treatment – enriched rectal swab c
Positive 19 1 20
Negative 2 109 111
Total 21 110 131
No IV treatment – bulk stool d
Positive 10 13 23
Negative 3 46 49
Total 13 59 72
NOTE: IV = intravenous fluids were given.
a Sensitivity was 100%; specificity was 93% (85–100); positive predictive value was 94%; and Kappa value was 0.93 (p < 0.05).
b Sensitivity was 97% (92–100%); specificity was 76% (62–89%); positive predictive value was 85%;and Kappa value was 0.74 (p < 0.05).
c Sensitivity was 91% (78–100%); specificity was 99% (97–100%); positive predictive value was 95%;and Kappa value was 0.91 (p < 0.05).
d Sensitivity was 77% (54–100%); specificity was 78% (67–89%); positive predictive value was 43%;and Kappa value was 0.42 (p < 0.05).BMC Infectious Diseases 2006, 6:17 http://www.biomedcentral.com/1471-2334/6/17
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men, the cholera prevalence and the experience of the
technicians gained over time, firstly, we calculated the
Pearson correlation coefficient for the type of stool speci-
men (rectal swab vs. bulk stool) and cholera prevalence
(the percentage of culture-positive specimens of total
specimens obtained biweekly). Subsequently, linear
regression model was applied by treating sensitivity and
specificity as response variables, and prevalence and pro-
portion as independent variables. A p-value less than .05
(two-tailed) was considered statistically significant. For
statistical analysis, we used an SAS program (version 8.2,
SAS Institute Inc., Cary, NC, USA).
Results
From 1 January to 31 May 2004, stool specimens from
391 patients were tested by conventional culture and by
the dipstick test. Conventional culture detected V. cholerae
more frequently in younger patients, in those with more
severe clinical signs and symptoms who required IV rehy-
dration, and in those who provided a bulk stool specimen
(Table 1).
Overall, the sensitivity, specificity, PPV, and Kappa value
were 95% (95% CI: 91%–99%), 89% (95% CI: 86%–
93%), 83%, and 0.82 (p < 0.05), respectively. We com-
pared the performance of the rapid dipstick by type of
fecal specimen tested (219 rectal swabs, 172 bulk stool
specimens). The overall sensitivity and specificity of the
rapid test with rectal swabs were 97% (95% CI: 93%–
100%) and 97% (95% CI: 95%–100%), respectively, and
the PPV was 94%. In contrast, the sensitivity, specificity,
and PPV of bulk stool were 93% (95% CI: 87%–99%),
77% (95% CI: 69%–85%), and 74%, respectively. The
rapid dipstick had a higher sensitivity when rectal swabs
were examined after 6 hours enrichment compared to
Sensitivity and specificity of the rapid dipstick test by month as related to cholera prevalence (% of tested specimens positive)  and % of specimens that were rectal swabs Figure 1
Sensitivity and specificity of the rapid dipstick test by month as related to cholera prevalence (% of tested specimens positive) 
and % of specimens that were rectal swabs.
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bulk stool specimens irrespective whether the patients
were or were not treated with IV fluids (table 2).
Of the 391 patients from whom specimens were tested,
188 received IV fluids. If only patients who required IV
rehydration were considered, the overall sensitivity of the
rapid test was 98% (95% CI: 95%–100%), specificity was
85% (95%CI: 77%–92%), and the PPV was 89%. In con-
trast, the overall sensitivity and specificity among patients
who did not require IV rehydration were 85% (95% CI:
73%–97%) and 92% (95% CI: 88%–96%) and the PPV
was 67%. The rapid dipstick had a higher sensitivity when
specimens from patients receiving IV therapy were exam-
ined than specimens from patients who did not receive IV
therapy irrespective whether bulk stool or enriched rectal
swabs were examined (table 2).
The performance characteristics of the rapid tests
improved over time (Figure 1). During the first month of
testing, the sensitivity and specificity were 80% and 77%,
respectively. The sensitivity and specificity for the subse-
quent 4 months increased to 97% and 92%. The perform-
ance of the rapid tests peaked in March when sensitivity
and specificity were 100% and 92%, respectively. Correla-
tion was observed not only among the sensitivity, specifi-
city, proportion of rectal swab and cholera prevalence but
also between the specificity and time (p < 0.05). However,
significant correlation was only found between the chol-
era prevalence and the specificity (p = 0.04) when linear
regression model was applied. The residual diagnostics
did not provide any strong evidence for the violation of
linearity and normality assumption for the linear regres-
sion model.
Of 391 tests, 52 tests lacked control lines but had strong
test lines. If these tests were excluded from the analysis,
the overall sensitivity, specificity, PPV and Kappa value
based on the remaining 339 tests were 92% (95% CI:
86%–98%), 90% (95% CI: 86%–94%), 76% and 0.76 (p
< 0.05) respectively.
Discussion
This simple, one-step dipstick test performed well in the
diagnosis of cholera in a setting with minimal facilities,
where rapid tests are most urgently needed. Diagnostic
testing may not be necessary for the clinical management
of each diarrhea patient during an outbreak. The dipstick
test may be helpful to confirm clinically suspected cholera
cases, especially during the start of an outbreak. Once a
cholera outbreak has been confirmed, large-scale preven-
tive measures, including mass vaccinations and improve-
ment of water and sanitation could be mobilized to
minimize morbidity and mortality [3,5].
In our study, the overall sensitivity and specificity of the
dipstick test were 95% and 89%, respectively. The per-
formance of IP rapid test varied with the severity of disease
and by type of specimen tested. The test was more sensi-
tive for specimens from patients with life-threatening
cholera who required IV rehydration than for specimens
from patients with less severe disease. Patients treated
with IV fluids may have more severe disease and their
stool specimens may have a higher bacterial concentra-
tion than specimens from patients with milder illness
[10,11]. The test had higher sensitivity as well as specifi-
city after enrichment of rectal swabs in APW for 6 hours
compared with direct immersion in bulk stool. The most
likely explanation is that the use of Cary Blair transporta-
tion medium and the 6 hours enrichment may increase
bacterial concentration of rectal swab. Because of the close
correlation between the type of specimen tested (bulk
stool or enriched rectal swab) and the treatment received
by the patient (IV or no IV rehydration) we compared the
performance characteristics of the rapid test in four sub-
groups. The subgroup analysis indicated higher sensitivity
of the rapid test in IV treated patients with presumably
more severe disease than patients with less severe disease,
not requiring IV rehydration. The explanation for these
observations may lie in differences in bacterial load. The
enrichment of stool specimens derived from rectal swabs
may increase bacterial concentrations to higher levels
than bacterial concentrations found in bulk stool speci-
mens. Specimens from patients receiving IV therapy may
contain a higher bacterial load than specimens from
patients not receiving IV therapy. The rapid test is least
sensitive for mild cholera episodes, which are most diffi-
cult to recognize clinically.
In this study, the test performed less well during the first
month of the study, likely because of incorrect use of and
interpretation of results. We included the early test results
in the overall evaluation of the dipstick test because we
believe it is important to understand the dynamic charac-
ter of the performance characteristics of the rapid test. It
can be expected that the initial use of the rapid test will
produce less satisfactory results than during routine use of
the test. Since the first use of the assay may be critical in
the detection of a cholera outbreak, cautious interpreta-
tion of initial test results may be indicated.
The absence of a positive control line in the presence of a
very strong positive test line is likely related to heavy load
of V. cholerae O1 LPS. Ideally, tests with absent control
lines and strong test lines should have been retested after
dilution of the fecal specimen. We did suggest adding the
dilution step to resolve results which are difficult to inter-
pret. However, under real field circumstances this is
unlikely to be done because of additional time and man-
power requirements. An alternative approach, interpret-BMC Infectious Diseases 2006, 6:17 http://www.biomedcentral.com/1471-2334/6/17
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ing all tests with an absent control line as invalid,
probably results in an unacceptable decline in the sensi-
tivity and PPV of the test. In practice, study staff found it
easy to recognize strong positive test lines even in the
absence of control lines and to interpret them correctly.
The problem has been discussed with the manufacturer
and hopefully will be resolved in future generations of the
test.
Several rapid diagnostic tests based on monoclonal anti-
bodies against V. cholerae O1 or O139 have been evalu-
ated [4,12-16]. Though the sensitivity and specificity of
these tests exceeded 95%, these assays are more compli-
cated than the dipstick test and may not be suitable for use
in the field [14,16]. In the earlier studies, the sensitivity
and specificity of the dipstick test were 94%–100% and
84%–100%, respectively, very similar to the characteris-
tics we found after the first month of study. The margin-
ally better performance of the test in earlier studies may be
explained by the more sophisticated laboratory infrastruc-
ture as well as the different disease spectrum in earlier
studies [6,7].
In our study, the results of dipstick assay could be inter-
preted objectively with stool culture as the reference
standard. Thus, other common confounders or biases of
diagnostic studies, namely influence of clinical factors on
test interpretation and reference standard error were
unlikely to affect the validity of our evaluation [17,18].
Conclusion
In conclusion, the dipstick test for detection of V. cholerae
O1 is an accurate and easy-to-perform assay that does not
need special equipment. It remains unknown how well
the test performs directly in the hands of primary health-
care providers at a patient's bedside. We expect the per-
formance will be similar as our findings during the first
month of our study. Further studies are indicated to eval-
uate this assay in crisis situations, but the logistics may
make such an undertaking even more challenging.
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